Gerhard G. Grabenbauer

11.7k total citations · 2 hit papers
179 papers, 6.8k citations indexed

About

Gerhard G. Grabenbauer is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gerhard G. Grabenbauer has authored 179 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Oncology, 65 papers in Surgery and 57 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gerhard G. Grabenbauer's work include Head and Neck Cancer Studies (41 papers), Glioma Diagnosis and Treatment (27 papers) and Colorectal and Anal Carcinomas (22 papers). Gerhard G. Grabenbauer is often cited by papers focused on Head and Neck Cancer Studies (41 papers), Glioma Diagnosis and Treatment (27 papers) and Colorectal and Anal Carcinomas (22 papers). Gerhard G. Grabenbauer collaborates with scholars based in Germany, Switzerland and Australia. Gerhard G. Grabenbauer's co-authors include Rolf Sauer, Claus Rödel, Luitpold Distel, Gerald Niedobitek, Franz Rödel, Werner Hohenberger, Thomas Papadopoulos, Thomas Brunner, Oliver Ganslandt and Ulrike Lambrecht and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

In The Last Decade

Gerhard G. Grabenbauer

175 papers receiving 6.7k citations

Hit Papers

Simultaneous radiochemoth... 1998 2026 2007 2016 1998 2002 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.
    1998 499 citations Thomas Wendt, Gerhard G. Grabenbauer et al. Journal of Clinical Oncology profile →
  2. Combined-Modality Treatment and Selective Organ Preservation in Invasive Bladder Cancer: Long-Term Results
    2002 462 citations Claus Rödel, Gerhard G. Grabenbauer et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerhard G. Grabenbauer Germany 42 3.1k 2.7k 2.0k 1.2k 1.0k 179 6.8k
Véronique Mosseri France 47 2.7k 0.9× 1.4k 0.5× 1.2k 0.6× 403 0.3× 1.9k 1.8× 122 7.4k
Amanda Psyrri Greece 48 3.7k 1.2× 1.4k 0.5× 1.7k 0.8× 2.1k 1.7× 2.5k 2.4× 251 7.2k
Kazuhiko Ogawa Japan 39 1.3k 0.4× 1.2k 0.5× 2.0k 1.0× 376 0.3× 1.2k 1.2× 320 5.7k
W.H. Lau China 34 2.7k 0.9× 1.9k 0.7× 1.0k 0.5× 2.2k 1.8× 493 0.5× 63 5.3k
Bayardo Perez‐Ordoñez Canada 51 4.0k 1.3× 4.5k 1.7× 1.6k 0.8× 2.9k 2.5× 2.4k 2.3× 206 9.6k
E. Brian Butler United States 35 1.2k 0.4× 973 0.4× 2.1k 1.0× 433 0.4× 792 0.8× 227 4.7k
Peter B. Illei United States 48 2.7k 0.9× 1.6k 0.6× 3.9k 1.9× 271 0.2× 2.7k 2.5× 151 8.3k
Cécile Badoual France 39 2.6k 0.8× 1.4k 0.5× 1.2k 0.6× 642 0.5× 1.2k 1.2× 193 6.2k
Matthew G. Fury United States 38 2.1k 0.7× 1.0k 0.4× 1.3k 0.6× 1.2k 1.0× 881 0.8× 165 4.4k
Chad Tang United States 37 2.8k 0.9× 1.2k 0.5× 2.0k 1.0× 266 0.2× 2.2k 2.1× 187 7.3k

Countries citing papers authored by Gerhard G. Grabenbauer

Since Specialization
Citations

This map shows the geographic impact of Gerhard G. Grabenbauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard G. Grabenbauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard G. Grabenbauer more than expected).

Fields of papers citing papers by Gerhard G. Grabenbauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerhard G. Grabenbauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard G. Grabenbauer. The network helps show where Gerhard G. Grabenbauer may publish in the future.

Co-authorship network of co-authors of Gerhard G. Grabenbauer

This figure shows the co-authorship network connecting the top 25 collaborators of Gerhard G. Grabenbauer. A scholar is included among the top collaborators of Gerhard G. Grabenbauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerhard G. Grabenbauer. Gerhard G. Grabenbauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fokas, Emmanouil, Michael Flentje, Rolf Sauer, et al.. (2020). Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial. European Journal of Cancer. 144. 281–290. 13 indexed citations
2.
Stupp, Roger, Monika E. Hegi, Bart Neyns, et al.. (2010). Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma. Journal of Clinical Oncology. 28(16). 2712–2718. 341 indexed citations
3.
Rohrer, Tilman, et al.. (2010). Growth Hormone Therapy and the Risk of Tumor Recurrence after Brain Tumor Treatment in Children. Journal of Pediatric Endocrinology and Metabolism. 23(9). 935–42. 25 indexed citations
4.
Kuhnt, Thomas, Thomas Wendt, Rita Engenhart‐Cabillic, et al.. (2010). Phase I trial of dose-escalated cisplatin with concomitant cetuximab and hyperfractionated-accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck. Annals of Oncology. 21(11). 2284–2289. 21 indexed citations
5.
Fenner, Matthias, Jung Park, Norbert S. Schulz, et al.. (2009). Validation of histologic changes induced by external irradiation in mandibular bone. An experimental animal model. Journal of Cranio-Maxillofacial Surgery. 38(1). 47–53. 41 indexed citations
6.
Grabenbauer, Gerhard G., Oliver Ganslandt, Andréa Richter, et al.. (2009). Effects of Concurrent Topotecan and Radiation on 6-Month Progression-Free Survival in the Primary Treatment of Glioblastoma Multiforme. International Journal of Radiation Oncology*Biology*Physics. 75(1). 164–169. 16 indexed citations
7.
Rohrer, Tilman, et al.. (2009). Late endocrine sequelae after radiotherapy of pediatric brain tumors are independent of tumor location. Journal of Endocrinological Investigation. 32(4). 294–297. 22 indexed citations
8.
Beck, Jörn‐Dirk, et al.. (2008). Ergebnisse der multidisziplinären Behandlung lokalisierter Ewing-Sarkome bei Kindern und Jugendlichen. Strahlentherapie und Onkologie. 184(3). 137–144. 17 indexed citations
9.
Ernst‐Stecken, Antje, et al.. (2006). Dose Escalation in Large Anterior Skull-Base Tumors by Means of IMRT. Strahlentherapie und Onkologie. 182(3). 183–189. 18 indexed citations
10.
Grabenbauer, Gerhard G., et al.. (2006). Inter-relation of apoptosis and DNA double-strand breaks in patients with multiple primary cancers. European Journal of Cancer Prevention. 15(3). 274–282. 4 indexed citations
11.
Brunner, Thomas, et al.. (2006). Molecular verification of stereotactic radiotherapy in rats using ATMpS1981 immunofluorescence. Radiotherapy and Oncology. 79(1). 109–114. 6 indexed citations
12.
Keßler, P., et al.. (2004). [Patients with oral squamous cell carcinoma. Long-term survival and evaluation of quality of life-initial results obtained with two treatment protocols in a prospective study].. Mund- Kiefer- und Gesichtschirurgie. 8(5). 302–310. 10 indexed citations
13.
Keller, Ulrike, Alma Kuechler, Thomas Liehr, et al.. (2004). Impact of Various Parameters in Detecting Chromosomal Aberrations by FISH to Describe Radiosensitivity. Strahlentherapie und Onkologie. 180(5). 289–296. 28 indexed citations
14.
Ganslandt, Oliver, et al.. (2003). Simple invasive fixation device for fractionated stereotactic LINAC based radiotherapy. Acta Neurochirurgica. 145(4). 289–294. 1 indexed citations
15.
Grabenbauer, Gerhard G., Claus Rödel, Antje Ernst‐Stecken, et al.. (2003). Neck dissection following radiochemotherapy of advanced head and neck cancer – for selected cases only?. Radiotherapy and Oncology. 66(1). 57–63. 74 indexed citations
16.
Rödel, Claus, Gerhard G. Grabenbauer, Reinhard Kühn, et al.. (2002). Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil. International Journal of Radiation Oncology*Biology*Physics. 52(5). 1303–1309. 33 indexed citations
17.
Grabenbauer, Gerhard G., et al.. (2002). Invasive Bladder Cancer: Organ Preservation by Radiochemotherapy. Frontiers of radiation therapy and oncology. 36. 118–130. 6 indexed citations
18.
Sauer, Rolf, Werner Hohenberger, Christian Wittekind, et al.. (1999). Neoadjuvante radiochemotherapie von weichteilsarkomen. Strahlentherapie und Onkologie. 175(6). 259–266. 30 indexed citations
19.
Grabenbauer, Gerhard G., H Steininger, Martin Meyer, et al.. (1998). Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer. Radiotherapy and Oncology. 47(2). 175–183. 71 indexed citations
20.
Fietkau, Rainer, H Iro, Gerhard G. Grabenbauer, A. Altendorf-Hofmann, & Rolf Sauer. (1991). [Simultaneous radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in advanced head and neck tumors].. PubMed. 167(12). 693–700. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Véronique Mosseri Breakdown of academic impact, for papers by Amanda Psyrri Breakdown of academic impact, for papers by Kazuhiko Ogawa Breakdown of academic impact, for papers by W.H. Lau Breakdown of academic impact, for papers by Bayardo Perez‐Ordoñez Breakdown of academic impact, for papers by E. Brian Butler Breakdown of academic impact, for papers by Peter B. Illei Breakdown of academic impact, for papers by Cécile Badoual Breakdown of academic impact, for papers by Matthew G. Fury Breakdown of academic impact, for papers by Chad Tang
Rankless by CCL
2026